CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2015; 05(02): 022-027
DOI: 10.1055/s-0040-1703884
Original Article

MOLECULAR DETECTION OF RUBELLA VIRUS GLYCOPROTEIN AMONG WOMEN OF CHILDBEARING AGE IN LOKOJA

O M Kolawole
1   Senior Lecturer, Department of Microbiology, University of Ilorin, Nigeria
,
M M Suleiman
2   Research Scholars, Medical Microbiology, Department of Microbiology, University of Ilorin, Nigeria
,
O AlabI
3   Consultant Gynecologist, Federal Medical Centre, Lokoja, Nigeria
,
I J Ogah
4   Research Scholars, Medical Microbiology, Department of Microbiology, University of Ilorin, Nigeria
,
O O Amuda
5   Research Scholars, Medical Microbiology, Department of Microbiology, University of Ilorin, Nigeria
› Institutsangaben

Abstract

Background: The gene order for the Rubella virus (RV)40S RNA is 5' -p150-p90-C-E2-E1-3' and the complete nucleotide sequence of RV has been determined for three strains. The RV core is surrounded by a host-derived lipid bilayer containing 5-6nm long spikes composed of the E2 and E1 glycoproteins

Objective(s): Molecular detection of Rubella virus glycoprotein after serum screening of 240 women attending Federal Medical Centre Lokoja (FMC) via IgG and IgM ELISA.

Method: Cross-sectional study was carried out in Obstetrics and Gynecology clinic at FMC Lokoja. Serology for anti RV-IgG and IgM was done for 240 blood samples after serum separation. Polymerase Chain Reaction (PCR) was done for rubella cDNA via RUB 2 & 7 and RUB 8 & 11 specific primers and this was sequenced using dye terminator cycle sequencing.

Result: 231(96.25%) of 240 and 4(1.7%) of 231 subjects were positive to Rubella IgG and IgM respectively after assay. PCR band result had 320bp on 1kb DNA plus ladder of 0.9μg/lane and live blast of the 320 length sequence result revealed a Rubella membrane glycoprotein E1 (Rubella_E1). All subjects that had blood transfusion were positive to Rub-IgG (p=0.566) while 3(1.6%) of 168(88.9%) respondents with no blood transfusion were IgM positive (P= 0.537). 61(32.6%) of 67(35.8%) respondent who reported history of rash were positive to Rub-IgG (p=0.057) and of 30(22.7%) that has had a miscarriage, 29(22.0%) was positive to Rub-IgG (p=0.731)

Conclusion: Rubella virus membrane glycoprotein E1, an important structural type 1 membrane protein in the entire pathogenesis of rubella virus has been confirmed in this locality.



Publikationsverlauf

Artikel online veröffentlicht:
27. Juni 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Geo FB, Janet SB, Stephen AM. 2004. Rubella. International edition, McGraw-Hill Companies, Asia 23: pp. 566–568.
  • 2 Wolinsky JS, Knipe DM. 1996 Rubella in Fields 'Virology, ed. by Fields, Philadelphia, Lippen Cott-Raven; pp. 899–929.
  • 3 Marchler-Bauer A and Bryant SH. 2004. Protein domain annotations on the fly; Nucleic acid resource. 32(w) 327-331.
  • 4 Dominguez, G., Wang, C., Frey, T. (1990). Sequence of the genome RNA of rubella virus. Evidence for genetic rearrangement during togavirus evolution. Virology. 177(1); 225.
  • 5 Yao, J., Yang, D., Chong, P., Hwang, D., Liang, Y. and Gillam, S. (1998). Proteolytic processing of rubella virus nonstructural proteins. Virology. 246;74–82.
  • 6 Pugachev, K.V. and Frey, T.K. (1998). Rubella virus induces apoptosis in culture cells. Virology. 250; 359–370.
  • 7 Yang, D., Hwang, D., Qiu, Z. and Gillam, S. (1998). Effects in the mutation in the rubella virus E1 glycoproteins on E1-E2 interaction and membrane fusion activity. Journal of Virology. 72:8747–8755.
  • 8 Araoye MO. 2004. Research methodology with statistics for health and social science. Sample size determination. Nathadex publishers: 118-21.
  • 9 World Health Organization. Rubella vaccines. 2000. WHO position paper; Wkly Epidemiol Rec 75:161-975:161-9.
  • 10 Obijimi TO, Ajetomobi AB, Sule WF, Oluwayelu DO. 2013. Prevalence of rubella virus-specific immunoglobulin-g and -m in pregnant women attending two tertiary hospitals in Southwestern Nigeria. Afr. J. Cln. Exper. Microbiol 14(3):134-139.
  • 11 Agbede OO, Adeyemi OO, Olatinwo AWO, Salisu TJ, Kolawole OM. 2011. Sero-Prevalence of Antenatal Rubella in UITH. The Open Public Health Journal 4:10-16.
  • 12 Junaid, S.A., Akpan, K.J. and Olabode, A.O. (2011). Sero-survey of rubella IgM antibodies among children in Jos, Nigeria. Virology Journal. 8;244
  • 13 María del MM., Fernando de O, Mónica M, Juan, E. 2002. Simultaneous Detection of Measles Virus, Rubella Virus, and Parvovirus B19 by Using Multiplex PCR. Journal of clinical microbiology. 40(1); 111–116.
  • 14 Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Lu F, Marchler GH, Mullokandov M, Omelchenko MV, Robertson CL, Song JS, Thanki N, Yamashita RA, Zhang D, Zheng C, Bryant SH. 2004. Nucleic Acid Resources. E-public medicine; d205-10.
  • 15 Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Lu F, Marchler GH, Mullokandov M, Omelchenko MV, Robertson CL, Song JS, Thanki N, Yamashita RA, Zhang D, Zheng C, Bryant SH. 2009. Nucleic Acid Resources. E-public medicine; d205-10.
  • 16 Petruzziello R., Orsi N., Macchia S., Rieti S., Frey T, Mastromarino P. 1996. Pathway of rubella virus infectious entry into Vero cells. J. Gen. Virol. 77:303–308.
  • 17 Hobman, T.C. and Gillam, S. (1989). In vitro and in vivo expression of rubella virus glycoprotein E2: the signal peptide is contained in the Cterminal region of capsid protein. Virology. 173; 241–250.
  • 18 Hobman, T., Chantler, J., Knipe, D.M., Howley, P.M., Griffin, D.E., Martin, M.A., Lamb, R.A., Roizman, B. and Straus, S.E. (2007). Rubella Virus. Virology, 5thed. PA, USA: Lippincott Williams & Wilkins; 1069-1100
  • 19 Garbutt, M., Law, M. J., Chan, H. and Hobman, T. C. (1999). Role of rubella virus glycoprotein domains in assembly of virus-like particles. Journal of Virology. 73; 3524–3533.